⚠ Retracted Article
RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret(Hung Yen University of Technology and Education), Didier Raoult(Aix-Marseille Université), Line Meddeb(Méditerranée Infection Foundation), Van Thuan Hoang(Aix-Marseille Université), Barbara Doudier(Méditerranée Infection Foundation), Bernard La Scola(Institut Pasteur de Bangui), Johan Courjon(Centre Méditerranéen de Médecine Moléculaire), Morgane Mailhe(Aix-Marseille Université), Jean‐Christophe Lagier(Méditerranée Infection Foundation), Philippe Colson(Aix-Marseille Université), Philippe Parola(Aix-Marseille Université), Hervé Dupont(Centre Hospitalier Universitaire Amiens-Picardie), Vera Esteves Vieira(Méditerranée Infection Foundation), Éric Chabrière(Centre National de la Recherche Scientifique), Philippe Brouqui(Méditerranée Infection Foundation), Jean‐Marc Rolain(Méditerranée Infection Foundation), Stéphane Honoré(Aix-Marseille Université), Valérie Giordanengo(Centre Hospitalier Universitaire de Nice)
Cited by 4,962
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
|Frontiers in Microbiology|2014|1.4k
Ticks and Tickborne Bacterial Diseases in Humans: An Emerging Infectious Threat
|Clinical Infectious Diseases|2001|1.3k
RETRACTED ARTICLE: Culture of previously uncultured members of the human gut microbiota by culturomics
|Nature Microbiology|2016|896
Genome sequences of the human body louse and its primary endosymbiont provide insights into the permanent parasitic lifestyle
|Proceedings of the National Academy of Sciences|2010|585